Drug intelligence / Profile preview

PHySIOMIC

Development stage
Preclinical
Lead developer
Inserm
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

PHySIOMIC (Polydopamine Hybridized Self-assembled Iron Oxide Mussel Inspired Clusters) is a biodegradable, superparamagnetic iron oxide-based contrast agent designed for the non-invasive detection and imaging of microthrombi. Developed by researchers at INSERM, CHU Caen, and the Blood and Brain Institute (BB@C Caen Normandie) in collaboration with CSL Behring, PHySIOMIC consists of superparamagnetic iron oxide nanoparticles (SPIO) clustered within a polydopamine matrix. The polydopamine coating mimics the adhesive properties of mussels, facilitating the formation of a protein corona (specifically involving fibrinogen) in the bloodstream that targets microthrombi. PHySIOMIC is being investigated as an imaging agent for Magnetic Resonance Imaging (MRI) and Magnetic Particle Imaging (MPI) to visualize microvascular thrombosis in conditions such as acute ischemic stroke and pulmonary embolism.

Other names
PHYSIOMICPolydopamine Hybridized Self-assembled Iron Oxide Mussel Inspired ClustersPolydopamine Self-Hybridized Superparamagnetic Iron Oxide Mussel-Inspired Clusters

Beyond the preview

Go deeper on PHySIOMIC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHySIOMIC.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call